Philadelphia

October 28, 2024:  Top Considerations when Engaging a Potential Strategic Partnership

   Gaspar Taroncher-Oldenburg, Director Therapeutic Alliances, NYU Langone

   Napoleon Alejandro, Director, Drug Development & Regulatory Strategy, Early

      Phase Development Solutions, Labcorp

   Robert Eric Besthof, COO, RiboNova & Head of Operations & Strategy, Evrys Bio

   Tim Atkins, Partner, Goodwin

   Moderated by Manjula Donepudi, VP, Business Development & Partnering, Evotec

April 15, 2024:  Investment & Partnership Opportunities in the Current Life Science Ecosystem

   Bob Drakas, President, ShangPharma Innovation

   Brian McVeigh, CEO & Co-Founder, Code Bio

   Marian Nakada, VP, Venture Investments, JJDC, J&J

   Tingting Zhang-Kharas, Head, JLABS US Northeast, J&J

November 2, 2023:  Harnessing your Investments: Doing More with Less

   Jennifer Griffin, Partner, Mission BioCapital

   Katie McCarthy, Chief Innovation Officer, Halloran Consulting Group

   Lalo Flores, CEO, stealth newco

   Nick Siciliano, CEO, viTToria bioTherapeutics

   Moderated by Ann Darda, Managing Director, Danforth Advisors

May 24, 2023:  Successes & Challenges in the Science of Cell & Gene Therapies

   Mike Cohen, Managing Partner, Osage University Partners

   Tracy Dowling, General Counsel & Head of BD, AskBio

   John Maris, Co-Founder, Hulu Therapeutics & Division of Oncology, CHOP

   Dan Takefman, former Head of Regulatory Affairs, Spark Therapeutics & former

      Chief of  Gene Therapy Branch, US FDA

   Moderated by Kendra Rose, SVP & Head of BD & L, OI New Platforms,

      Cardiovascular &  Immunology, Bayer Pharmaceuticals